| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
atypical chemokine receptor 2 | 0.641 | 0.615 | 1.4E-03 |
|
phenotype | 0.040 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
acid phosphatase 5, tartrate resistant | 0.561 | 0.731 | 7.9E-02 |
|
phenotype | 0.040 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
actin alpha 1, skeletal muscle | 0.540 | 0.769 | 1.1E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
actin related protein 2 | 0.659 | 0.654 | 1.00 |
|
phenotype | 0.060 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.955 | 1 | 0 | 2007 | 2019 | ||||||||
|
ADAM metallopeptidase domain 12 | 0.565 | 0.731 | 5.7E-07 |
|
phenotype | 0.070 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.917 | 1 | 0 | 2007 | 2019 | ||||||||
|
ADAM metallopeptidase domain 23 | 0.650 | 0.500 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 1 | 0 | 2005 | 2015 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 | 0.555 | 0.654 | 0.72 |
|
phenotype | 0.070 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
phenotype | 0.040 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 2003 | 2020 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 2 | 0 | 2002 | 2020 | ||||||||
|
activated leukocyte cell adhesion molecule | 0.502 | 0.808 | 0.73 |
|
phenotype | 0.100 | None | 0.957 | 1 | 0 | 2004 | 2019 | ||||||||
|
alpha-1-microglobulin/bikunin precursor | 0.537 | 0.731 | 2.8E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 2000 | 2012 | ||||||||
|
autocrine motility factor receptor | 0.599 | 0.692 | 5.8E-05 |
|
phenotype | 0.070 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
angiopoietin 2 | 0.410 | 0.846 | 0.83 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 2001 | 2020 | ||||||||
|
annexin A2 | 0.453 | 0.808 | 9.8E-05 |
|
phenotype | 0.100 | None | 1.000 | 3 | 0 | 1993 | 2019 | ||||||||
|
annexin A2 receptor | 0.821 | 0.346 |
|
phenotype | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2018 | |||||||||
|
apoptotic peptidase activating factor 1 | 0.525 | 0.769 | 9.6E-06 |
|
phenotype | 0.070 | None | 0.857 | 1 | 0 | 2004 | 2017 | ||||||||
|
apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.458 | 0.846 | 1.9E-07 |
|
phenotype | 0.090 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 0.986 | 1 | 0 | 1997 | 2020 | ||||||||
|
arginase 1 | 0.476 | 0.846 | 3.6E-04 |
|
phenotype | 0.030 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
Rho GTPase activating protein 35 | 0.751 | 0.269 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 1 | 0 | 2008 | 2016 |